| pubmed-article:12241774 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C1522318 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C0247025 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C0288672 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C0439851 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C0522523 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C0581603 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C0016441 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C0522776 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C0439231 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C1552596 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C1947931 | lld:lifeskim |
| pubmed-article:12241774 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
| pubmed-article:12241774 | pubmed:issue | 9330 | lld:pubmed |
| pubmed-article:12241774 | pubmed:dateCreated | 2002-9-20 | lld:pubmed |
| pubmed-article:12241774 | pubmed:abstractText | Two placebo-controlled trials testing intravenous platelet glycoprotein IIb/IIIa antagonists in the setting of percutaneous coronary revascularisation with intracoronary stents have shown a durable reduction in ischaemic events to 6 months. These trials differed regarding their patient population, IIb/IIIa inhibitor, and reported extent of benefit. Whether a small-molecule agent affecting only the IIb/IIIa receptor would provide a similar outcome for ischaemic events and clinical restenosis at 6 months when directly compared with a monoclonal antibody known to affect several integrin receptors is unknown. | lld:pubmed |
| pubmed-article:12241774 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12241774 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12241774 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12241774 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12241774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12241774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12241774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12241774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12241774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12241774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12241774 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12241774 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12241774 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:12241774 | pubmed:issn | 0140-6736 | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:TopolEric JEJ | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:ArdissinoDieg... | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:StoneGregg... | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:NeumannFranz-... | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:MacayaCarlosC | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:MoliternoDavi... | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:YeungAlan CAC | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:HerrmannHowar... | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:DiBattistePet... | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:BassandJean-P... | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:DemopoulosLau... | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:HarrisKatheri... | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:YakubovSteven... | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:BorziLynnL | lld:pubmed |
| pubmed-article:12241774 | pubmed:author | pubmed-author:TARGET... | lld:pubmed |
| pubmed-article:12241774 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12241774 | pubmed:day | 3 | lld:pubmed |
| pubmed-article:12241774 | pubmed:volume | 360 | lld:pubmed |
| pubmed-article:12241774 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12241774 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12241774 | pubmed:pagination | 355-60 | lld:pubmed |
| pubmed-article:12241774 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:meshHeading | pubmed-meshheading:12241774... | lld:pubmed |
| pubmed-article:12241774 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12241774 | pubmed:articleTitle | Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study. | lld:pubmed |
| pubmed-article:12241774 | pubmed:affiliation | Department of Cardiovascular Medicine and C5 (Cleveland Clinic Cardiovascular Coordinating Center), Cleveland Clinic Foundation, Cleveland, OH 44195, USA. molited@ccf.org | lld:pubmed |
| pubmed-article:12241774 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12241774 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12241774 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:12241774 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12241774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12241774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12241774 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12241774 | lld:pubmed |
